Potential responses to remifentanil supply shortages.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36057481.
- Also identified by DOI 10.1016/j.bja.2022.08.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Rapid elimination of remifentanil facilitates application of intense opioid effect during general anaesthesia whilst maintaining prompt emergence. Interruptions in remifentanil supply mean clinicians must relearn titration of pharmacokinetically longer-acting opioids to achieve appropriate levels of opioid effect whilst maintaining acceptable recovery times. Opioid-free anaesthesia is achievable for many minor and intermediate surgical procedures for which remifentanil might have been used previously.
Medical subject headings
- Anesthetics, Intravenous
- Propofol